{"title": "Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines", "author": "Nancy S Jecker; Aaron G Wightman; Douglas S Diekema", "url": "https://jme.bmj.com/content/47/5/308", "hostname": "bmj.com", "description": "This paper addresses the just distribution of vaccines against the SARS-CoV-2 virus and sets forth an ethical framework that prioritises frontline and essential workers, people at high risk of severe disease or death, and people at high risk of infection. Section I makes the case that vaccine distribution should occur at a global level in order to accelerate development and fair, efficient vaccine allocation. Section II puts forth ethical values to guide vaccine distribution including helping people with the greatest need, reducing health disparity, saving the most lives and promoting narrow social utility. It also responds to objections which claim that earlier years have more value than later years. Section III puts forth a practical ethical framework to aid decision-makers and compares it with alternatives.", "sitename": "Journal of Medical Ethics", "date": "2021-05-01", "cleaned_text": "Article Text Abstract This paper addresses the just distribution of vaccines against the SARS-CoV-2 virus and sets forth an ethical framework that prioritises frontline and essential workers, people at high risk of severe disease or death, and people at high risk of infection. Section I makes the case that vaccine distribution should occur at a global level in order to accelerate development and fair, efficient vaccine allocation. Section II puts forth ethical values to guide vaccine distribution including helping people with the greatest need, reducing health disparity, saving the most lives and promoting narrow social utility. It also responds to objections which claim that earlier years have more value than later years. Section III puts forth a practical ethical framework to aid decision-makers and compares it with alternatives. - allocation of healthcare resources - distributive justice - ethics - public health ethics - COVID-19 This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. [https://bmj.com/coronavirus/usage](https://bmj.com/coronavirus/usage) Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center's RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. Footnotes Contributors All authors contributed to developing ideas and arguments contained in the paper, researching and writing the manuscript. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed. Read the full text or download the PDF: Other content recommended for you [Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya](https://doi.org/10.1136/bmjgh-2022-009430) [Love thy neighbour? Allocating vaccines in a world of obligations](https://doi.org/10.1136/medethics-2020-106887) [Vaccine equity in COVID-19: a prioritisation: rethinking the approach](https://doi.org/10.1136/medethics-2020-107117) [Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies](https://doi.org/10.1136/bmjopen-2020-044640) [Considerations for vaccinating COVID-19](https://doi.org/10.1136/bmjpo-2023-001964) [Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries](https://doi.org/10.1136/bmjopen-2021-049505) [Towards a new model of global health justice: the case of COVID-19 vaccines](https://doi.org/10.1136/medethics-2022-108165) [Do coronavirus vaccine challenge trials have a distinctive generalisability problem?](https://doi.org/10.1136/medethics-2020-107109) [A vaccine tax: ensuring "}